Evidence map›Paper›PMID 35630709›Full record

ReviewMolecules (Basel, Switzerland)2022

Cardiovascular Disease and Possible Ways in Which Lycopene Acts as an Efficient Cardio-Protectant against Different Cardiovascular Risk Factors.

Ming-Ju Hsieh, Chih-Yang Huang, Rudolf Kiefer, Shin-Da Lee, Nancy Maurya, Bharath Kumar Velmurugan

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Ming-Ju HsiehOral Cancer Research Center, Changhua Christian Hospital, Changhua 50006, Taiwan.ORCID 0000-0001-9726-3234
Chih-Yang HuangDepartment of Medical Laboratory Science and Biotechnology, Asia University, Taichung 41354, Taiwan.ORCID 0000-0003-2347-0411
Rudolf KieferConducting Polymers in Composites and Applications Research Group, Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 758307, Vietnam.ORCID 0000-0001-7692-6705
Shin-Da LeeDepartment of Physical Therapy, Asia University, Taichung 41354, Taiwan.ORCID 0000-0002-8393-8349
Nancy MauryaBotany Department, Government Science College, Pandhurna, Chhindwara, M.P., Pandhurna 480334, India.
Bharath Kumar VelmuruganFaculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City 758307, Vietnam.ORCID 0000-0002-4786-9913
Ton Duc Thang University · VNAsia University · TWNational Chung Hsing University · TWWeifang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Foods rich in antioxidants such as lycopene have a major role in maintaining cardiac health. Lycopene, 80% of which can be obtained by consuming a common vegetable such as tomato, can prevent the disturbances that contribute to cardiovascular disease (CVD). The present work begins with a brief introduction to CVD and lycopene and its various properties such as bioavailability, pharmacokinetics, etc. In this review, the potential cardio-protective effects of lycopene that reduce the progression of CVD and thrombotic complications are detailed. Further, the protective effects of lycopene including in vitro, in vivo and clinical trials conducted on lycopene for CVD protective effects are explained. Finally, the controversial aspect of lycopene as a protective agent against CVD and toxicity are also mentioned.

Indexed as

Cardiovascular DiseasesAntioxidantsCarotenoidsHeart Disease Risk FactorsHumansLycopeneRisk FactorsAntioxidantsCarotenoidsLycopenecardiovascular diseasein vitro studiesin vivo studieslycopenepharmacokinetics

Identifiers

PMID35630709
PMCPMC9147660
OpenAlexW4280625248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.